Delaware Health Information Network (DHIN) and Pathology Lab Partner with iSpecimen to Bring COVID-19 Specimens to Researchers

Delaware Health Information Netwok (DHIN) and Pathology Lab partners with iSpecimen® to bring COVID-19 specimens to researchers. Through the iSpecimen Marketplace, medical researchers can now access a new daily source of biospecimens from patients who have recently taken COVID-19 tests and consented to release their de-identified data.

Read details

> you might also like:

NRHI Publishes Findings from Phase II of Off-Site Testing Research in Peer-Reviewed “Healthcare: The Journal of Delivery Science and Innovation”

January 15, 2021

Many off-site COVID-19 testing centers (OSCTCs) are struggling with strategies to serve vulnerable populations who have some of the highest rates of COVID-19 cases, hospitalizations, and deaths. Inter-OSCTC sharing of...

Comagine Health Launches The Partnership to Reimagine Health Care Initiative

January 15, 2021

Comaine Health launched The Partnership to Reimagine Health Care initiative. The latter is part of a national initiative to improve care for people with Medicare. It began in 2019 and ends...

Stratis Health Continues to Publish Quality Time: Sharing PIE (Performance Improvement Experience) podcasts

January 14, 2021

The national virtual Quality Improvement Mentors share their lived experience in finding the right recipe to advance quality in their critical access hospitals through Quality Time: Sharing PIE (performance improvement experience) conversations. Periodically, a...

Delaware Health Information Network (DHIN) and Pathology Lab Partner with iSpecimen to Bring COVID-19 Specimens to Researchers

Share: